Icmr Clinical Trials
-
{
- All
- News
- Videos
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
India Close To Launching Dengue Vaccine, Final Trials Underway
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Tissue Sample Moved 37 Km In 20 Min, Mid-Surgery, For Cancer Testing
The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.
-
India Completes Clinical Trials Of World's 1st Injectable Male Contraceptive
The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
India Close To Launching Dengue Vaccine, Final Trials Underway
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Tissue Sample Moved 37 Km In 20 Min, Mid-Surgery, For Cancer Testing
The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.
-
India Completes Clinical Trials Of World's 1st Injectable Male Contraceptive
The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
